Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Sodium valproate 333.3 mg and valproic acid 145.14 mg prolonged-release oral granules sachet |
Is a |
Valproic acid only product in oral dose form |
true |
Inferred relationship |
Some |
|
|
Sodium valproate 333.3 mg and valproic acid 145.14 mg prolonged-release oral granules sachet |
Has manufactured dose form |
Prolonged-release oral granules (dose form) |
true |
Inferred relationship |
Some |
|
|
Sodium valproate 333.3 mg and valproic acid 145.14 mg prolonged-release oral granules sachet |
Has unit of presentation |
Sachet (unit of presentation) |
true |
Inferred relationship |
Some |
|
|
Sodium valproate 333.3 mg and valproic acid 145.14 mg prolonged-release oral granules sachet |
Plays role |
Anticonvulsant therapeutic role (role) |
false |
Inferred relationship |
Some |
|
|
Sodium valproate 333.3 mg and valproic acid 145.14 mg prolonged-release oral granules sachet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Valproic acid (substance) |
true |
Inferred relationship |
Some |
1 |
|
Sodium valproate 333.3 mg and valproic acid 145.14 mg prolonged-release oral granules sachet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Valproic acid (substance) |
true |
Inferred relationship |
Some |
1 |
|
Sodium valproate 333.3 mg and valproic acid 145.14 mg prolonged-release oral granules sachet |
This attribute specifies the numerator unit for the presentation strength of a product. |
mg |
true |
Inferred relationship |
Some |
1 |
|
Sodium valproate 333.3 mg and valproic acid 145.14 mg prolonged-release oral granules sachet |
This attribute specifies the denominator unit for the presentation strength of a product. |
Sachet (unit of presentation) |
true |
Inferred relationship |
Some |
1 |
|
Sodium valproate 333.3 mg and valproic acid 145.14 mg prolonged-release oral granules sachet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Sodium valproate |
true |
Inferred relationship |
Some |
2 |
|
Sodium valproate 333.3 mg and valproic acid 145.14 mg prolonged-release oral granules sachet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Sodium valproate |
true |
Inferred relationship |
Some |
2 |
|
Sodium valproate 333.3 mg and valproic acid 145.14 mg prolonged-release oral granules sachet |
This attribute specifies the numerator unit for the presentation strength of a product. |
mg |
true |
Inferred relationship |
Some |
2 |
|
Sodium valproate 333.3 mg and valproic acid 145.14 mg prolonged-release oral granules sachet |
This attribute specifies the denominator unit for the presentation strength of a product. |
Sachet (unit of presentation) |
true |
Inferred relationship |
Some |
2 |
|